Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Debt / NOTE 1.250% 5/1
-
Unit price / market price
-
$0.9500
-
Total 13F principal
-
$547,434,225
-
Principal change
-
+$31,836,711
-
Total reported value
-
$521,865,010
-
Number of holders
-
58
-
Value change
-
+$30,970,903
-
Number of buys
-
24
-
Number of sells
-
28
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1 as of Q3 2025
As of 30 Sep 2025 BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1 had 58 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $547,434,225 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included TENOR CAPITAL MANAGEMENT Co., L.P., Voya Investment Management LLC, BlackRock, Inc., MACKAY SHIELDS LLC, Opti Capital Management, LP, CAPSTONE INVESTMENT ADVISORS, LLC, Wellesley Asset Management, MILLENNIUM MANAGEMENT LLC, OAKTREE CAPITAL MANAGEMENT LP, and VICTORY CAPITAL MANAGEMENT INC.
This table shows 58 bond principal holders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.